EVOLVERAI

Owners

Goods & Services

Providing online nondownloadable computer software using artificial intelligence for automated machine learning in the field of drug design and development; Providing online nondownloadable computer software using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Providing online nondownloadable computer software using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immune-oncology; Providing online nondownloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Providing online nondownloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Providing online nondownloadable software for molecular research, research and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Providing online nondownloadable artificial intelligence software for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immuno-oncology; Providing online nondownloadable software using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immune-oncology; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Platform as a service (PaaS) featuring computer software platforms for molecular research, research and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immuno-oncology; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; Pharmaceutical and biopharmaceutical research and development; Pharmaceutical and biopharmaceutical research and development in the fields of neuroscience and immuno-oncology; Scientific and medical research in the fields of pharmaceuticals, biologic testing and interpretation, neuroscience, and immuno-oncology; Research and development of pharmaceuticals, biological preparations, and therapeutic products and medicines.

Downloadable computer software using artificial intelligence for automated machine learning in the field of drug design and development; Downloadable computer software using artificial intelligence for collecting, analyzing, interpreting, and reporting data and information for drug design and development; Downloadable computer software using artificial intelligence for automated machine learning for drug design and development in the fields of neuroscience and immuno-oncology; Downloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Downloadable computer software using artificial intelligence for the discovery and development of therapeutic agents and indices in the fields of neuroscience and immune-oncology; Downloadable computer software for molecular research, research and develop and development of pharmaceutical products and chemical compounds, and analysis of biological or chemical activity in the fields of pharmaceuticals, biopharmaceuticals, and healthcare; Downloadable artificial intelligence software for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, development, and response prediction in the fields of neuroscience and immune-oncology; Downloadable software using artificial intelligence and incorporating computational methods and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development.